Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression
2011
The phenotypic range of hemophilia A carriers.
1976
Differentiation Stage-Specific Requirement in Hypoxia-Inducible Factor-1α–Regulated Glycolytic Pathway during Murine B Cell Development in Bone Marrow
2009 StandoutNobel
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Sp1 Sites Mediate Activation of the Plasminogen Activator Inhibitor-1 Promoter by Glucose in Vascular Smooth Muscle Cells
1998
Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial
1999
Congenital antithrombin III deficiency
1989
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
A Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting
2004 Standout
Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1
2001
Cushing's syndrome
2015 Standout
Tissue Destruction by Neutrophils
1989 Standout
A longitudinal study of biochemical variables in women at risk of preeclampsia
2002
Abdominal aortic aneurysm
2005 Standout
Development and Disease in Proteinase-Deficient Mice
1998
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
Angiogenesis in cancer and other diseases
2000 StandoutNature
COPD exacerbations: defining their cause and prevention
2007
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The Fibrinolytic System of the Vessel Wall and Its Role in the Control of Thrombosis
1990
Platelet Activation and Atherothrombosis
2007 Standout
Pre-eclampsia
2005 Standout
Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome
1998
The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets
2012 StandoutNobel
Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre‐eclampsia
2002
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
Mutation in blood coagulation factor V associated with resistance to activated protein C
1994 StandoutNature
A Prospective Study of Venous Thromboembolism after Major Trauma
1994 Standout
11 The molecular genetics of familial venous thrombosis
1994
The potential role of platelet microparticles in atherosclerosis
2005
The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease
1994
Nitric Oxide Is Generated on the Skin Surface by Reduction of Sweat Nitrate
1996
An Antibody Fragment from a Phage Display Library Competes for Ligand Binding to the Low Density Lipoprotein Receptor Family and Inhibits Rhinovirus Infection
1995 StandoutNobel
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
1996 Standout
Hemostatic alterations in cancer patients
1992
Clinical Evidence of Peroxynitrite Formation in Chronic Renal Failure Patients with Septic Shock
1997
Role of Plasminogen-Activator Inhibitor Type 1 in the Pathogenesis and Outcome of the Hemolytic Uremic Syndrome
1992
Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator
1990
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Transgenic mouse models in angiogenesis and cardiovascular disease
2000
The Cell Adhesion Domain in Plasma Vitronectin Is Cryptic
1997
Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.
1998
World distribution of factor V Leiden
1995 Standout
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)
2014
Prevention and Treatment of Postoperative Nausea and Vomiting
2000
Atherosclerosis
2001 Standout
Is nitric oxide overproduction the target of choice for the management of septic shock?
2001
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
Partially hydrogenated soybean oil reduces postprandial t-PA activity compared with palm oil
2001
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
TRPV3 regulates nitric oxide synthase-independent nitric oxide synthesis in the skin
2011 StandoutNobel
Synthetic fibrinolytic agents
1979
Plasminogen activator inhibitors
1987
Migration of transfused granulocytes in leukopenic dogs
1977
On the Regulation and Control of Fibrinolysis
1980
Serpin Structure, Mechanism, and Function
2002 Standout
HÆMOPHILIA CARRIERS
1974
Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
1993 StandoutNobel
Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage
2006
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.
1992
Thrombin Activates the Hypoxia-Inducible Factor-1 Signaling Pathway in Vascular Smooth Muscle Cells
2001
Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain
1984 StandoutScience
The mechanism of in vitro clot lysis induced by vascular plasminogen activator
1984
Permanent cell line expressing human factor VIII-related antigen established by hybridization.
1983 Standout
Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator.
1992
Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urine
1983
Biological implications of a 3 å structure of dimeric antithrombin
1994
Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance.
1992
The coupling ATPase complex: An evolutionary view
1981
Neutralization of Human Extrinsic (Tissue-Type) Plasminogen Activator in Human Plasma: No Evidence for a Specific Inhibitor
1981
Glycobiology: Toward Understanding the Function of Sugars
1996 Standout
Plasminogen activators, activation inhibitors and alpha2‐macroglobulin produced by cultured normal and malignant human cells
1984
Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells
1993
Defective forebrain development in mice lacking gp330/megalin.
1996 Standout
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold.
1982 StandoutNobel
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic Purpura
1982 Standout
The Hypercoagulable States
1985
Epidemiology of coagulation disorders
1992
Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor.
1994 StandoutNobel
Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.
1981
Evidence for the Occurrence of a Fast-Acting Inhibitor for Tissue-Type Plasminogen Activator in Human Plasma
1984
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
COAGULATION DISORDERS IN CANCER
1996
Prevention of Aneurysm Development and Rupture by Local Overexpression of Plasminogen Activator Inhibitor-1
1998
Inactivation of plasminogen activator inhibitor by oxidants
1986
Treatment of Experimental Cerebral Ischemia
1982
Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
1975
Coronary Plaque Disruption
1995 Standout
Altered Factor VIII in Acute Respiratory Failure
1982
Induction of the Plasminogen Activator Inhibitor-1 Gene Expression by Mild Hypoxia Via a Hypoxia Response Element Binding the Hypoxia-Inducible Factor-1 in Rat Hepatocytes
1999
Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma.
1986
No crossreaction between circulating plasminogen activator and urokinase
1979
Low-affinity heparin stimulates the inactivation of plasminogen activator inhibitor-1 by thrombin
1994
The Pathogenesis of Atherosclerosis
1976 Standout
Tumors: Wounds That Do Not Heal
1986 Standout
Isolation of plasminogen activator from human plasma by chromatography on lysine-Sepharose
1978
Expression of hypoxia-inducible factor 1? in brain tumors
2000 StandoutNobel
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Relationship between tissue plasminogen activator and the activators in blood and vascular wall
1980
Complex-formation and inhibition of urokinase by blood plasma proteins
1983
Deep Venous Thrombosis and Pulmonary Embolism in Trauma Patients
1988
Granulocyte Transfusions for the Prevention of Infection in Patients Receiving Bone-Marrow Transplants
1978 StandoutNobel
Platelet Physiology and Abnormalities of Platelet Function
1975 Standout
Platelet Physiology and Abnormalities of Platelet Function
1975
Works of Bruce Bennett being referenced
Plasma nitrate concentrations in neutropenic and non‐neutropenic patients with suspected septicaemia
1995
p53 mutation in the myelodysplastic syndromes
1995
Frequency of venous thrombosis in patients with an exacerbation of chronic obstructive lung disease.
1983
Plasminogen activator inhibitor (PAI‐1) in plasma and platelets
1988
Plasminogen activator inhibitors (PAI‐1 and PAI‐2) in normal pregnancies, pre‐eclampsia and hydatidiform mole
1993
The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u‐PA rather than defibrination
1989
Lysis of Platelet‐rich Thrombi: The Role of PAI–1a
1992
The receptor for tissue plasminogen activator (t‐PA) in complex with its inhibitor, PAI‐1, on human hepatocytes
1991
Inhibitors of Plasminogen Activation in Human Blood
1976
The plasma inhibitors of plasminogen activator, studied by a zymographic technique
1985
SURFACE-MEDIATED REACTIONS IN THE FORMATION OF THROMBIN, PLASMIN AND KALLIKREIN
1978
Immunologic Studies in von Willebrand's Disease
1972
Studies on the Nature of Antihemophilic Factor (Factor VIII)
1973
Inhibitors of Fibrinolysis Are Elevated in Atherosclerotic Plaque
1996
Properties of a partially purified preparation of a circulating plasminogen activator
1976
Distribution of plasminogen activator inhibitor (PAI-1) in tissues.
1991
Pseudomonas Septicemia in Neutropenic Dogs I. Treatment with Granulocyte Transfusions
1974
Detection of the Carrier State for Classic Hemophilia
1973
A new life-long hemorrhagic disorder due to excess plasminogen activator
1983
HAEMOSTATIC RESPONSE TO TRAUMA
1985
Confirmation of linkage between antithrombin III and Duffy blodd group and assignment of AT3 to 1q22 → q25
1982
Proteins of the Fibrinolytic System in Human Thrombi
1996
POSTOPERATIVE NAUSEA AND VOMITING
1961
Clearance of t-PA, PAI-1, and t-PA-PAI-1 complex in an isolated perfused rat liver system.
1991
Platelet release protein which inhibits plasminogen activators.
1985
Plasmin‐a2‐antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis
1984
Familial antithrombin III deficiency.
1982
Comparative Studies on Human Activators of Plasminogen
1981
The Genetics of Hereditary Disorders of Blood Coagulation
1973 Science
The Inhibition of Urokinase by Alpha2-Macroglobulin
1973
Changes in antihemophilic factor (AHF, factor 8) procoagulant activity and AHF-like antigen in normal pregnancy, and following exercise and pneumoencephalography.
1972